Skip to Content

MYLAN TM 180 MYLAN TM 180 (Temozolomide 180 mg)

Pill with imprint MYLAN TM 180 MYLAN TM 180 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Mylan Pharmaceuticals Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN TM 180 MYLAN TM 180

Temozolomide

Imprint:
MYLAN TM 180 MYLAN TM 180
Strength:
180 mg
Color:
Orange & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5264

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide